<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
<channel>
<title><![CDATA[RSS for Sanofi S.A.]]></title>
<description><![CDATA[Watch breaking news videos and read news updates about Sanofi S.A. on FOXBusiness.com.]]></description>
<link><![CDATA[http://www.foxbusiness.com/search-results/]]></link>
<atom:link xmlns:atom="http://www.w3.org/2005/Atom" type="application/rss+xml" rel="self" href="http://www.foxbusiness.com/search-results/urss?pageid=940317"/>
<item>
<title><![CDATA[Regeneron-Sanofi Asthma Drug Shows Promising Early Results]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/21/regeneron-sanofi-asthma-drug-shows-promising-early-results/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/21/regeneron-sanofi-asthma-drug-shows-promising-early-results/</guid>
<pubDate><![CDATA[Tue, 21 May 2013 12:16:55 EDT]]></pubDate>
<description><![CDATA[An experimental drug being developed by Regeneron Pharmaceuticals Inc. (REGN) and Sanofi SA (SNY) showed promising results during a small, mid-stage clinical trial in treating a subset of patients with moderate to severe asthma, but some physicians cautioned that it was too early to say how effective the treatment may ultimately be.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Sanofi Could Exit Toulouse Site in 5 Years]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/17/sanofi-could-exit-toulouse-site-in-5-years/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/17/sanofi-could-exit-toulouse-site-in-5-years/</guid>
<pubDate><![CDATA[Fri, 17 May 2013 15:19:26 EDT]]></pubDate>
<description><![CDATA[Sanofi SA (SAN.FR) will forge ahead with plans to restructure its French research and development operations, but will take five years to transform operations at its Toulouse R&D site into "autonomous structures," the company said Friday.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Sanofi Reports Positive Results on Study on Inhibitor in Myelofibrosis]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/17/sanofi-reports-positive-results-on-study-on-inhibitor-in-myelofibrosis/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/17/sanofi-reports-positive-results-on-study-on-inhibitor-in-myelofibrosis/</guid>
<pubDate><![CDATA[Fri, 17 May 2013 01:24:39 EDT]]></pubDate>
<description><![CDATA[French pharmaceutical giant Sanofi SA (SAN.FR) Friday announced a pivotal study examining JAK2 inhibitor SAR302503 for myelofibrosis (MF) had positive results.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[French Antitrust Authority Fines Sanofi EUR40.6 Million]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/14/french-antitrust-authority-fines-sanofi-eur406-million/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/14/french-antitrust-authority-fines-sanofi-eur406-million/</guid>
<pubDate><![CDATA[Tue, 14 May 2013 05:51:03 EDT]]></pubDate>
<description><![CDATA[France's antitrust authority said Tuesday it has decided to fine French drugs giant Sanofi SA (SAN.FR) 40.6 million euros ($52.8 million) for what it called a "smear campaign" against certain generic drugs.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Medicare Overpaid $529 Million for Anemia Drugs in 2011 - Report]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/10/medicare-overpaid-52-million-for-anemia-drugs-in-2011-report/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/10/medicare-overpaid-52-million-for-anemia-drugs-in-2011-report/</guid>
<pubDate><![CDATA[Fri, 10 May 2013 11:31:10 EDT]]></pubDate>
<description><![CDATA[Medicare paid $529 million more than it should have for antianemia drugs used in the treatment of kidney dialysis patients, a new government report finds, putting further pressure on regulators to reduce its payments for drugs manufactured by Amgen Inc. (AMGN) and others.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[EUROPE MARKETS: Europe Stocks End Higher After U.S. Data]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/09/europe-markets-europe-stocks-end-higher-after-us-data/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/09/europe-markets-europe-stocks-end-higher-after-us-data/</guid>
<pubDate><![CDATA[Thu, 09 May 2013 12:02:47 EDT]]></pubDate>
<description><![CDATA[German stocks extended their record streak into a third straight day on Thursday, while a pan-European equity index erased losses to end higher after better-than-expected U.S. jobs data.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[EUROPE MARKETS: Europe Stocks Trim Losses After U.S. Data]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/09/europe-markets-europe-stocks-trim-losses-after-us-data/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/09/europe-markets-europe-stocks-trim-losses-after-us-data/</guid>
<pubDate><![CDATA[Thu, 09 May 2013 10:36:21 EDT]]></pubDate>
<description><![CDATA[German stocks were flirting with extending its record streak into a third straight day on Thursday, while the broader European stock markets trimmed losses after better-than-expected U.S. jobs data.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[EUROPE MARKETS: Europe Stocks Slip After Chinese Inflation Data]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/09/europe-markets-europe-stocks-slip-after-chinese-inflation-data/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/09/europe-markets-europe-stocks-slip-after-chinese-inflation-data/</guid>
<pubDate><![CDATA[Thu, 09 May 2013 08:06:34 EDT]]></pubDate>
<description><![CDATA[European stock markets retreated Thursday, after higher-than-expected Chinese inflation data stoked fears the Chinese government will withhold more easing measures.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Americans Spending Less on Medicines]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/08/us-spending-on-medicines-fell-for-first-time-in-2012/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/08/us-spending-on-medicines-fell-for-first-time-in-2012/</guid>
<pubDate><![CDATA[Wed, 08 May 2013 23:59:59 EDT]]></pubDate>
<description><![CDATA[Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years, according to a report released on Thursday.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/medicine_pills_health_care.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[EUROPE MARKETS: Europe Stocks Still Choppy After ECB Rate Cut]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/02/europe-markets-europe-stocks-still-choppy-after-ecb-rate-cut/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/02/europe-markets-europe-stocks-still-choppy-after-ecb-rate-cut/</guid>
<pubDate><![CDATA[Thu, 02 May 2013 08:38:49 EDT]]></pubDate>
<description><![CDATA[European stock markets stayed choppy after a European Central Bank rate cut on Thursday, showing muted reaction to the widely expected move.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[European Stocks Cautious Ahead Of ECB Meeting]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2013/05/02/european-stocks-cautious-ahead-ecb-meeting/?]]></link>
<guid>http://www.foxbusiness.com/markets/2013/05/02/european-stocks-cautious-ahead-ecb-meeting/</guid>
<pubDate><![CDATA[Thu, 02 May 2013 03:18:00 EDT]]></pubDate>
<description><![CDATA[European stock markets drifted lower on Thursday, as investors await a European Central Bank meeting, with expectations for an interest rate cut.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Merck 1st-Quarter Profit Down on Loss of Singulair Exclusivity]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/01/merck-1st-quarter-profit-down-on-loss-singulair-exclusivity/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/01/merck-1st-quarter-profit-down-on-loss-singulair-exclusivity/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 15:58:38 EDT]]></pubDate>
<description><![CDATA[Major drug makers are finding it more difficult than expected to overcome the blow of recent patent expirations, with Merck & Co. (MRK) becoming the second company after Pfizer Inc. (PFE) to report disappointing sales for the first quarter and lower its full-year outlook.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[EUROPE MARKETS: Europe Stocks End Lower But Germany's DAX Gains]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/30/europe-markets-europe-stocks-end-lower-but-germany-dax-gains/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/30/europe-markets-europe-stocks-end-lower-but-germany-dax-gains/</guid>
<pubDate><![CDATA[Tue, 30 Apr 2013 12:24:51 EDT]]></pubDate>
<description><![CDATA[European stock markets ended mostly lower on Tuesday following disappointing economic data, while strong gains for Deutsche Bank AG led the German stock index to a higher finish.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[EUROPE MARKETS: Germany A Bright Spot In A Down Europe Market]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/30/europe-markets-germany-bright-spot-in-down-europe-market/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/30/europe-markets-germany-bright-spot-in-down-europe-market/</guid>
<pubDate><![CDATA[Tue, 30 Apr 2013 11:10:47 EDT]]></pubDate>
<description><![CDATA[German stocks provided the lone bright spot in European stocks, where markets broadly fell on downbeat Europe and U.S. economic data and as investors stepped back ahead of key central-bank meetings.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[EARNINGS FORECAST TABLE: Sanofi 1Q 2013]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/30/earnings-forecast-table-sanofi-1q-2013/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/30/earnings-forecast-table-sanofi-1q-2013/</guid>
<pubDate><![CDATA[Tue, 30 Apr 2013 08:04:04 EDT]]></pubDate>
<description><![CDATA[The following is a summary of analysts' forecasts for Sanofi SA (SNY) first-quarter results, based on a poll of five analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS).]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Regeneron Pharmaceuticals Co-Founder Receives $81.55 Million Compensation]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/29/regeneron-pharmaceuticals-co-founder-receives-8155-million-compensation/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/29/regeneron-pharmaceuticals-co-founder-receives-8155-million-compensation/</guid>
<pubDate><![CDATA[Mon, 29 Apr 2013 14:49:11 EDT]]></pubDate>
<description><![CDATA[Regeneron Pharmaceuticals Inc.'s (REGN) stock price tripled last year, and the compensation of co-founder and Chief Executive Leonard Schleifer nearly did, too.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[EUROPE MARKETS: Italy Leads European Stock-market Gains]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/29/europe-markets-italy-leads-european-stock-market-gains/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/29/europe-markets-italy-leads-european-stock-market-gains/</guid>
<pubDate><![CDATA[Mon, 29 Apr 2013 12:06:20 EDT]]></pubDate>
<description><![CDATA[European stock markets notched moderate gains on Monday, while Italian stocks rallied on relief that a new government was sworn in over the weekend.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[EUROPE MARKETS: Italy Leads Europe Stocks Gains; ECB Optimism]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/29/europe-markets-italy-leads-europe-stocks-gains-ecb-optimism/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/29/europe-markets-italy-leads-europe-stocks-gains-ecb-optimism/</guid>
<pubDate><![CDATA[Mon, 29 Apr 2013 11:01:57 EDT]]></pubDate>
<description><![CDATA[European stock markets notched some moderate gains on Monday, with Italian stocks rallying on relief that a new government is finally in place.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[EUROPE MARKETS: Europe Stocks Bid Higher, With Italy In The Lead]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/29/europe-markets-europe-stocks-bid-higher-with-italy-in-lead/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/29/europe-markets-europe-stocks-bid-higher-with-italy-in-lead/</guid>
<pubDate><![CDATA[Mon, 29 Apr 2013 04:39:24 EDT]]></pubDate>
<description><![CDATA[European stock markets pushed higher in early trading on Monday, with drug stocks and banks providing support, and Italian stocks in the lead as a new government settled in.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Europe Stocks Slightly Up, Rentokil Jumps]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2013/04/29/europe-stocks-slightly-up-rentokil-jumps/?]]></link>
<guid>http://www.foxbusiness.com/markets/2013/04/29/europe-stocks-slightly-up-rentokil-jumps/</guid>
<pubDate><![CDATA[Mon, 29 Apr 2013 03:24:00 EDT]]></pubDate>
<description><![CDATA[European stock markets moved higher in early trading on Monday, as investors look ahead to a week that includes a potential interest-rate cut from the European Central Bank.]]></description>
<media:thumbnail/>
</item>
</channel>
</rss>
